A hub for improving cancer control research in underserved areas.
Official title: Research and Methods Core-002
Funded at University of Alabama at Birmingham · NIH-11082240 · Data updated 2026-11-12
This study is all about finding better ways to tackle cancer in communities facing ongoing poverty, and it aims to bring researchers and local partners together to share knowledge and improve how cancer research is done.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | June 15, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $328,161 |
| NIH project number | 5U54CA280770-03 |
| Project ID | NIH-11082240 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals living in persistent poverty areas who are affected by cancer or at risk of developing cancer.
✕Less likely to help
Patients who do not reside in persistent poverty areas or who are not affected by cancer may not benefit from this research.
What this research studies
This research focuses on enhancing cancer control efforts in areas affected by persistent poverty. It serves as a central resource for providing expertise in study design, statistical analysis, and data management for various cancer-related research projects. The core aims to promote collaboration among researchers and community partners, ensuring that findings are effectively disseminated and utilized. By standardizing data collection and analysis methods, the project seeks to improve the quality and impact of cancer research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer control strategies tailored to underserved populations.
How similar studies have gone: Similar research initiatives have shown promise in improving health outcomes in underserved communities, indicating a potential for success in this approach.
Where this research is happening
-
University of Alabama at Birmingham
Birmingham, United States Active
Researchers
- Principal investigator: Oates, Gabriela R — University of Alabama at Birmingham
- Study coordinator: Oates, Gabriela R
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Exploring how Down syndrome affects optic nerve health in kids
A study using a mouse model to understand why optic nerve problems are common in children with Down syndrome and how to prevent them.
-
Global bromocriptine trial for postpartum cardiomyopathy
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with peripartum cardiomyopathy.
-
Global Bromocriptine Add-on for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding the dopamine agonist bromocriptine to standard heart failure care helps postpartum women with a specific heart condition.
-
Global Bromocriptine Trial for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding bromocriptine to standard heart-failure care helps women with postpartum cardiomyopathy.
-
Bromocriptine as add-on therapy for postpartum cardiomyopathy across multiple sites
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with postpartum cardiomyopathy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.